Addiction Treatment: U.S. FDA Approves Zubsolv® for the Maintenance Treatment of Opioid Dependence

Published July 5, 2013

U.S. FDA Approves Zubsolv® for the Maintenance Treatment of Opioid Dependence
Filed under: Addiction Treatment

NEW YORK, July 5, 2013 /PRNewswire/ — Orexo U.S., Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Zubsolv (buprenorphine and naloxone) sublingual tablets …
Addiction Treatment – Yahoo! News Search Results